|Videos|May 25, 2023
Systemic Treatment Considerations for Basal Cell Carcinoma
Author(s)Justine Cohen, DO, Brent Moody, MD, FACP, FAAD
Dr Justine Cohen discusses her approach to systemic treatment selection in her patients with basal cell carcinoma; highlighting the importance of individualizing the treatment plan.
Advertisement
Episodes in this series
Advertisement
Related to this article
Gaurav Singh, MD, MPH, explains how pharmacokinetics, trial design, and real-world tolerability set sonidegib apart from vismodegib in locally advanced basal cell carcinoma and when to start systemic therapy earlier.
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermatology Times Monthly FDA and Pipeline Review: October 2026
2
Phase 3 Trial Supports Risankizumab for Pediatric Psoriasis
3
Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year
4
Updated HS Guidelines Emphasize Biologics and Early Intervention
5